Company news
|
17 October 2012 Sequoia Genetics has enrolled in the Skolkovo Innovation CentreThe solemn ceremony and awarding of new members took place in October in the recently opened Hypercube building of the Skolkovo Innovation Centre. 12 companies became residents of Skolkovo, among them Saint-Petersburg biotechnological Company Sequoia Genetics, a unit of Alkor Bio Group.
|
07 September 2012 Sequoia Genetics Company has successfully launched semiconductor DNA sequencerOn the basis of molecular genetics laboratory, a member of Alkor Bio group and the resident
of Scolkovo Innovation Center, the Sequoia Genetics Company has successfully
installed semiconductor DNA sequencing equipment
(“direct reading method”). This has been the first launch of such sequencer in Saint-Petersburg
and the tenth in Russian Federation. |
14 August 2012 Preparation and properties evaluation of the recombinant analogue of birch pollen allergen Betv1ABSTRACT Background. For wide introduction of the component allergy diagnostics in laboratory practice it is necessary to create methods of production, purification and verification of synthetic allergens. Major birch pollen protein Betv1, a representative of the superfamily PR-10, is interesting due to the high incidence of sensitization and the manifestation of cross-reactive properties. |
|
05 July 2012 Sequoia genetics Company launch the Project aimed to development of the interactive solution for personal genome analysis in medical purposesThe first integrated project aimed to development of the interactive infrastructure for personal genome analysis has been launched in Russia. Sequoia genetics Company, a member of Alkor Bio Group of Companies, has started to consolidate resources and knowledge in the field of DNA sequencing, human genetics, algorithmic biology and IT for the creation of the unique solution for personalized medicine. The «Personal Genome Diagnostics» project goal is to develop an interactive tool for geneticists which will make it possible to carry out all of required genetic tests based on whole genome sequencing data.
|
23 April 2012 Group ALKOR BIO: Stem Cells Bank of the TRANS-TECHNOLOGIES Company moved to a new special complex of "clean premises"In April the construction of the Stem Cells Bank’s “clean premises” Complex was finished in a new building of the bio-technological holding company Alkor Bio. After that the Bank moved to its clean area, especially prepared for it.
|
11 April 2012 The VEGA Company of the Company Group ALKOR BIO Took Part in the Science Conference Human Genome Meeting 2012On the 11-14th of March scientists of VEGA Company – Aleksandr Pavlov, the Chief of the Molecular Diagnostics Laboratory, and Arseny Smirnov, the Chief of the Molecular-Genetic Diagnostics Group, - were participants of the 16th conference HGM 2012 in Sidney (Australia). They made a report about the results of diagnostics test-systems in microchip format investigations for mucoviscidosis gene mutation determination.
|